Patients’ characteristics:
The median age of patients undergoing MVRe was 70.50 (42–86) years, and
71.50 (48–88) years in MVRp (p=0.75). In our study, 30 patients in MVRe
and 32 in MVRp were females (46.9% and 50% respectively, p=0.72). The
median weight was 79.50 (54–115) kg in MVRe and 77.50 (47–138) kg in
MVRp (p=0.90).
Clinically 73.4% of patients in MVRe and 79.7% in MVRp were admitted
with NYHA classification III/IV (p=0.36). EuroSCORE II was used to
predict the mortality risk in our population in a standard fashion (13).
The median EuroSCORE II in MVRe was 1.5% (0.56%–14.4%) and 1.67%
(0.5%–25.43%) in MVRp (p=0.2).
25 in MVRe and 24 in MVRp (39.1% and 37.5% respectively, p=0.86) had
non-requiring surgery coronary heart disease in their history. Previous
myocardial infarction in patient history was observed in 3.1% of MVRe
and 9.4% of MVRp (p=0.27). A history of atrial fibrillation has been
documented in 46.9% of patients in MVRe and 51.6% in MVRp (p=0.6). One
patient in each group had previous cardiac surgery, 2 patients in MVRe
and 7 in MVRp had at least one stroke in their history (p=0.16).
Of the 22 patients with diabetes mellitus, 8 underwent repair and 14
underwent replacement (12.5% and 21.9% respectively, p=0.16). 49
patients with obesity (BMI ≥ 30 kg/m2) were
identified, 22 underwent repair and 27 underwent replacement (34.4% and
42.2% respectively, p=0.36). Hypertension was observed in 105 patients,
repair was performed in 51 (79.7%) patients and replacement in 54
(84.4%) patients (p=0.49) (Tab 2).